TSHA(Taysha Gene Therapies, Inc.) · 内部人交易

TSHA(Taysha Gene Therapies, Inc.) 的内部人交易:医疗保健,生物技术。数据来自 SEC 公开申报与市场行情,不构成投资建议。

TSHA 最近的内部人买卖(Form 4)
交易日姓名职务类型股数价格
2026-07-10Nagendran SukumarPresident and Head of R&D公开市场卖出200,000$6.24
2026-04-10Nagendran SukumarPresident and Head of R&D公开市场卖出200,000$4.46
2026-02-04Alam KamranCHIEF FINANCIAL OFFICER公开市场卖出1,655$4.52
2026-01-26Alam KamranCHIEF FINANCIAL OFFICER公开市场卖出23,849$4.61
2026-01-26Nagendran SukumarPresident and Head of R&D公开市场卖出26,918$4.61
2026-01-26Nolan Sean P.Chief Executive Officer公开市场卖出41,312$4.61
2026-01-23Alam KamranCHIEF FINANCIAL OFFICER公开市场卖出78,968$4.75
2026-01-23Nagendran SukumarPresident and Head of R&D公开市场卖出89,132$4.75
2026-01-23Nolan Sean P.Chief Executive Officer公开市场卖出136,789$4.75
2026-01-12Nagendran SukumarPresident and Head of R&D公开市场卖出200,000$4.71
2025-12-01Nagendran SukumarPresident and Head of R&D公开市场卖出260,047$4.51
2025-11-28Nagendran SukumarPresident and Head of R&D公开市场卖出110,125$4.75
2025-09-10Nagendran SukumarPresident and Head of R&D公开市场卖出200,000$3.23
2025-08-21Nagendran SukumarPresident and Head of R&D公开市场卖出57,054$2.85
2025-08-21Alam KamranCHIEF FINANCIAL OFFICER公开市场卖出54,491$2.85
2025-05-30Manning Paul B10% 股东公开市场买入750,000$2.75

Taysha Gene Therapies, Inc. TSHA